This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Loh E et al. (1997) Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 336: 251–257
Teo KK et al. (2002) Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet 360: 1037–1043
Massie BM et al. (2004) The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail 10: 101–112
Acknowledgements
The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Verheugt, F. Is antithrombotic therapy a risk-free and beneficial treatment for patients with heart failure?. Nat Rev Cardiol 1, 80–81 (2004). https://doi.org/10.1038/ncpcardio0039
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0039